BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Neurology

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

The acquisition is one of the largest cross-border transactions in the medical device industry globally in recent years and is driven by strong growth oppo...

April 22, 2022 | News

TauRx's late-stage clinical trial reaches new milestone

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed treatment in t...

April 14, 2022 | News

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced tha...

March 22, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

March 13, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development

German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...

March 01, 2022 | News

Clarity advances to cohort 2 in the SARTATE™ neuroblastoma trial

No dose limiting toxicities (DLTs) have been reported in cohort 1 - The Safety Review Committee (SRC) has recommended the trial continues with the d...

February 02, 2022 | News

HMI Group Strengthens Specialist Offering, Acquires Majority Stake in Eagle Eye Centre

Health Management International Pte Ltd (HMI Group), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, has...

January 25, 2022 | News

Medtronic announces FDA approval of spinal cord stimulation therapy

Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management...

January 25, 2022 | News

Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

January 19, 2022 | News

SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...

January 12, 2022 | News

Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China

The drug is an innovative traditional Chinese medicine (TCM) independently developed by Yiling Pharmaceutical based on clinical practices, applicable to mi...

December 24, 2021 | News

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Cladrib...

December 22, 2021 | News

UK medical diagnostics firm strikes commercial licensing deal to help Parkinson’s diagnosis in China

· Artificial intelligence and wearable technology invented in UK is helping to diagnose and manage Pa...

December 14, 2021 | News

Stay Connected